Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Taysha Gene Therapies Grants Inducement Options to New Employees, Share Price Rises Significantly
Taysha Gene Therapies: Advancing Rett Syndrome Clinical Program Amid Revenue Challenges
Taysha*s Groundbreaking Milestone: Dosing TSHA-102 in Pediatric Patient for Rett Syndrome Trial
Taysha Gene Therapies Grants Stock Option to New Senior Vice President
Taysha Gene Therapies Inc Sets New Revenue Record of $4.746 Million, Signaling Bright Future Ahead
Despite Unexpected Net Loss, Taysha Gene Therapies Inc. Makes Strides Toward Success in Q1 2023
The company disclosed operating deficit in the third quarter of 2022
The company disclosed operating deficit in the third quarter of 2022